Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 17 publications
Thermal Sensitive Liposomes Improve Delivery of Boronated Agents for Boron Neutron Capture Therapy.
Journal: Pharmaceutical research
Published: February 22, 2019
Injectable Hydrogels for Localized Chemotherapy and Radiotherapy in Brain Tumors.
Journal: Journal of pharmaceutical sciences
Published: September 06, 2017
Enhancing proteasome-inhibitory activity and specificity of bortezomib by CD38 targeted nanoparticles in multiple myeloma.
Journal: Journal of controlled release : official journal of the Controlled Release Society
Published: August 03, 2017
Newly established myeloma-derived stromal cell line MSP-1 supports multiple myeloma proliferation, migration, and adhesion and induces drug resistance more than normal-derived stroma.
Journal: Haematologica
Published: April 16, 2016
A Hypoxia-Targeted Boron Neutron Capture Therapy Agent for the Treatment of Glioma.
Journal: Pharmaceutical research
Published: March 25, 2016
MEK inhibitor, TAK-733 reduces proliferation, affects cell cycle and apoptosis, and synergizes with other targeted therapies in multiple myeloma.
Journal: Blood cancer journal
Published: February 27, 2016
Spotlight on ixazomib: potential in the treatment of multiple myeloma.
Journal: Drug design, development and therapy
Published: January 27, 2016
Tris DBA palladium overcomes hypoxia-mediated drug resistance in multiple myeloma.
Journal: Leukemia & lymphoma
Published: October 01, 2015
A CD138-independent strategy to detect minimal residual disease and circulating tumour cells in multiple myeloma.
Journal: British journal of haematology
Published: August 10, 2015
Identification of ILK as a novel therapeutic target for acute and chronic myeloid leukemia.
Journal: Leukemia research
Published: April 24, 2015
Advancements in Tumor Targeting Strategies for Boron Neutron Capture Therapy.
Journal: Pharmaceutical research
Published: March 12, 2015
Last Updated: 09/26/2026